
BACKGROUNDThe Montreal Chest Institute has been leading important clinical and evaluative research in COPD over the last decades. Some of these applied clinical research projects have been carried out at a provincial level with the goal of developing and evaluating the impact of a self-management program... |
Following the gaps in care evaluation and presentations made back to the team, it was easier to find key people that wanted to get involved in improving the care provided to COPD patients.
A new committee was then created, the RECAP-MUHC Committee. This decision-making and operational committee included the following people:
The committee's role was to oversee the implementation strategies, to support the changes and their maintenance on the front lines and with management.
We first made an inventory of all the programs and resources available in our institution and easily accessible in our vicinity (community services). These included:
Based on these strengths, it was easier to prioritize and to determine how ambitious we could adapt our interventions/program/clinical pathways to our needs. The RECAP-MUHC Committee felt that we had the strengths to address many clinical practice changes simultaneously over a short period of time (within 1 year) for the clientele chosen in Step 1 (patients visiting the ER or admitted to the hospital).
Our specific objectives (measurable intermediate targets) were to:
Our interventions in this Phase are directed specifically at enhancing these areas of best practice. They thus become indicators of the quality of our COPD practices "Quality indicators".
